ANI PHARMACEUTICALS, INC Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- ANI PHARMACEUTICALS, INC share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2015-03-31 was 1.00K shares, a 96.67% decline year-over-year.
- ANI PHARMACEUTICALS, INC share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2014-12-31 was 7.00K shares.
- ANI PHARMACEUTICALS, INC share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2014-09-30 was 5.00K shares.
- ANI PHARMACEUTICALS, INC share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2014-06-30 was 0.00 shares.
- ANI PHARMACEUTICALS, INC share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2014 was 43.00K shares.
- ANI PHARMACEUTICALS, INC share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2013 was 0.00 shares.
- ANI PHARMACEUTICALS, INC share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2012 was 0.00 shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month |
|---|---|---|
| 2015-03-31 | 1.00K shares 10-Q · filed 2015-05-05 | 13.00K shares derived: sum of 4 quarters · filed 2015-05-05 |
| 2014-12-31 | 7.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-23 | 43.00K shares 10-K · filed 2015-02-23 |
| 2014-09-30 | 5.00K shares 10-Q · filed 2014-11-10 | |
| 2014-06-30 | 0.00 shares 10-Q · filed 2014-08-07 | |
| 2014-03-31 | 30.00K shares 10-Q · filed 2015-05-05 | |
| 2013-12-31 | 0.00 shares 10-K · filed 2015-02-23 | |
| 2012-12-31 | 0.00 shares 10-K · filed 2014-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |